Timothy Edwin Kelly - 22 Jun 2022 Form 4 Insider Report for Praxis Precision Medicines, Inc. (PRAX)

Role
Chief Financial Officer
Signature
/s/ Alex Nemiroff, as Attorney-in-Fact
Issuer symbol
PRAX
Transactions as of
22 Jun 2022
Transactions value $
$0
Form type
4
Filing time
24 Jun 2022, 16:46:06 UTC
Previous filing
13 Jun 2022
Next filing
21 Nov 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PRAX Stock Option (Right to Buy) Award $0 +65,000 $0.000000 65,000 22 Jun 2022 Common Stock 65,000 $2.12 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares underlying this stock option vest over a four-year period, with 25% vesting on June 22, 2023 and the remaining 75% vesting in 36 equal monthly installments thereafter, subject to the reporting person's continued service through each vesting date.